Special Issue "Chlamydia trachomatis Infections"
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 6951
Interests: Sexually Transmitted Disease; Chlamydia and Gonorrhea
Interests: international public health; sexual/reproductive health; infectious diseases; immunology; health education
Special Issues, Collections and Topics in MDPI journals
Chlamydia trachomatis is an obligate intracellular bacterial pathogen that primarily infects human mucosal sites and may lead to serious sequelae such as reproductive infertility in women or blinding trachoma. . Globally, C trachomatis is the most common sexually transmitted infection and is the leading cause of preventable blindness. The continued high prevalence and potential disease outcome from untreated infections underscore the need for aggressive public health interventions.
Tetracycline and macrolide antimicrobial agents are effective in the treatment of C. trachomatis but additional research is requited to better understand the pathogenesis to address ongoing high rates of transmission.
The molecular pathways involved in the pathophysiology of Chlamydial infections are not completely understood due to the difficulties in establishing reliable animal models and inability to genetically manipulate the organism to elucidate virulence mechanisms.
Overall, many important questions remain about the natural history of C. trachomatis infections, disease progression, epidemiology, and effective disease control strategies.
This Special issue is dedicated to C. trachomatis related pathology and epidemiology. Submissions from researchers investigating C. trachomatis infections and outcomes are welcome. The aim is to provide state-of-the art summaries of current knowledge and explore emerging developments in the understanding of the pathogen, the infection, or their global impact. We look forward to your contribution.
Dr. John Papp
Dr. Elena Ambrosino
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Chlamydia trachomatis
- Immunology & Immunogenetics
- Prevention and Treatment
- One Health
- Point of Care Testing
- Clinical Outcomes
- Public Health impact